story of the week
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
J. Clin. Oncol 2020 Feb 14;[EPub Ahead of Print], PD Brown, V Gondi, S Pugh, WA Tome, JS Wefel, TS Armstrong, JA Bovi, C Robinson, A Konski, D Khuntia, D Grosshans, TLS Benzinger, D Bruner, MR Gilbert, D Roberge, V Kundapur, K Devisetty, S Shah, K Usuki, BM Anderson, B Stea, H Yoon, J Li, NN Laack, TJ Kruser, SJ Chmura, W Shi, S Deshmukh, MP Mehta, LA KachnicFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.